Ultraviolet Blood Irradiation (UBI), also referred to as Light Blood Irradiation (LBI), has been administered to treat various conditions for decades. Even though UBI has been widely used, it has not been adopted as a standard of care. This can be explained by two primary reasons: no robust clinical studies and no Food and Drug Administration approval. Although general adoption remains elusive, robust claims have been made concerning the utility of UBI. Click on a condition below to review a summary of published clinical literature.
Although a few studies have assessed the clinical utility of UBI for the aforementioned conditions, these claims remain largely unsubstantiated. It is encouraging that an application may play such a diverse role in medicine, but UVLrx Therapeutics™ is dedicated to separating FACT from FICTION. Each of the aforementioned claims requires the completion of a well-designed clinical study with independent review board approval. This is a daunting and time-consuming endeavor, but it is an endeavor that UVLrx Therapeutics™ is proud to pursue!